Furthermore, current studies have revealed conflicting results on the role of the different isoforms of PPARs in various tumor types; most investigations have shown that PPAR-β/δ activation is linked to tumor progression, while PPAR-α and PPAR-γ are associated with an antitumor action [38]. The gene discussed is PPARG; the disease is neoplasm.